Table 3.
Comparison of biochemical parameters between the CB supplementation and the placebo treatments after 15 days supplementation (estimated marginal means ± 95% CI).
| Baseline | †p-Value | Post-Intake (Pre-Eccentric Exercise) | †p-Value | |||
|---|---|---|---|---|---|---|
| CB (n = 8) | Placebo (n = 8) | CB (n = 8) | Placebo (n = 8) | |||
| Fasting blood glucose (mg/dL) | 87.4 (80.1, 94.7) |
85.0 (80.02, 89.98) |
0.536 | 83.5 (78.0, 89.0) |
86.6 (80.3, 93.0) |
0.393 |
| Hemoglobin (g/dL) | 15.5 (15.1, 15.9) |
14.3 (13.0, 15.6) |
0.050 | 15.2 (14.6, 15.7) |
14.2 (13.1, 15.2) |
0.063 |
| Hematocrit (%) | 46.2 (45.1, 47.2) |
42.7 (40.3, 45.0) |
0.006 * | 45.4 (44.2, 46.5) |
42.6 (39.6, 45.5) |
0.057 |
| Red cell count (×1012/L) |
5.2 (5.0, 5.4) |
5.5 (4.8, 6.1) |
0.380 | 5.1 (5.0, 5.3) |
5.5 (4.8, 6.2) |
0.204 |
| White blood cell count (×109/L) | 5.9 (4.9, 6.8) |
7.7 (5.9, 9.6) |
0.052 | 5.8 (5.0, 6.6) |
7.4 (5.5, 9.4) |
0.083 |
| Neutrophils (% WBC) |
48.2 (42.4, 53.9) |
51.6 (45.2, 58.1) |
0.359 | 49.6 (42.8, 56.4) |
53.0 (46.0, 60.0) |
0.429 |
| Lymphocyte (% WBC) |
40.4 (35.7, 45.1) |
38.0 (31.6, 44.4) |
0.486 | 39.3 (33.2, 45.5) |
36.0 (30.2, 41.8) |
0.364 |
| Monocyte (% WBC) |
8.0 (5.8, 10.2) |
6.5 (5.7, 7.3) |
0.146 | 7.9 (6.8, 9.0) |
7.1 (6.5, 7.6) |
0.118 |
| Eosinophil (% WBC) |
2.9 (1.5, 4.3) |
3.4 (2.3, 4.5) |
0.546 | 2.6 (0.5, 4.7) |
3.3 (2.1, 4.4) |
0.528 |
| Basophils (% WBC) |
0.5 (0.3, 0.6) |
0.5 (0.3, 0.7) |
1.000 | 0.6 (0.3, 0.8) |
0.4 (0.2, 0.6) |
0.251 |
| Platelet count (x109/L) |
231.8 (180.8, 282.7) |
272.6 (239.1, 306.2) |
0.136 | 237.6 (205.8, 269.4) |
287.6 (232.0, 343.3) |
0.086 |
| Alkaline phosphatase (U/L) | 77.0 (62.9, 91.1) |
70.9 (58.5, 83.2) |
0.453 | 74.3 (61.2, 87.3) |
69.6 (56.8, 82.4) |
0.560 |
| Aspartate transaminase (U/L) | 19.8 (15.6, 23.9) |
15.9 (14.2, 17.5) |
0.059 | 19.8 (17.0, 22.5) |
16.6 (12.6, 20.7) |
0.157 |
| Alanine transaminase (U/L) | 19.3 (9.9, 28.6) |
16.5 (12.6, 20.4) |
0.531 | 17.6 (10.9, 24.3) |
17.3 (10.1, 24.4) |
0.929 |
| Blood urea nitrogen (mg/dL) | 15.2 (12.7, 17.6) |
14.7 (12.7, 16.7) |
0.728 | 14.3 (11.7, 16.8) |
13.3 (10.9, 15.7) |
0.517 |
| Albumin (gm/dL) |
4.6 (4.4, 4.7) |
4.7 (4.5, 4.9) |
0.419 | 4.6 (4.5, 4.7) |
4.6 (4.4, 4.9) |
0.910 |
†p-value was calculated by the independent t-test. * = significant difference between baseline and post-intake values calculates by the independent t-test (p < 0.05).